i asked replicor and wait for their answer . we also were supposed to had the Gilead vaccine trial here but because of bureaucracy and the laws here it was suspended
Have you contacted them about participating in that trial or in future phase 3 one ? Maybe ask your doctor to contact with them.
the hbv/hdv trial is in moldavia, part of my country ...i hope they will continue here with trials and i would get on one whit hbv
it's in phase 2 now for hbv/hdv coinfection.
Is there any latest news about its launch ??
Well. Lets write to replicor again and ask for the drug.
What we need to do is to keep the pressure on these companies to release these medications.
If they are short on funds as it being said they and we all should raise funds online. It is easily done.
I see all these medications out there and they tell us 4-5 years some of wont make it.
We have to write to the companies and have them come here and read some of the life shattering stories of lives we live.
i just checked and after they published it is able to block the spread of infection from cell to cell it is almost disappered
Any news from Myrcludex-b makers?
they are really looking for the worst hbv carriers to treat with no immune response and no response to all other drugs
i think they want to show that they have better response where all drugs are totally useless, this way it will be easier to get approval....even easier than showing hbv eradication on normal carriers
Got same response from them..................................
The drug is still under development and is not yet available for purchase.
It will take a few years before it becomes available to patients. At this
time, only patients enrolled in a clinical trial can receive the drug. We
expect the drug to continue performing very well for patient with chronic
hepatitis B.
To enter the clinical trial, a patients must fit the inclusion and exclusion criteria on the study and be willing to live in Dhaka, Bangladesh for at least 6 months.
Your DNA count needs to be higher than 10 millions copies per ml of blood to qualify.